Verge Genomics

Verge Genomics (now operating as Verge Labs) is an AI-driven drug discovery biotechnology company using human genomics data and machine learning to discover and develop treatments for neurodegenerative and neuromuscular diseases such as ALS and Parkinson's. Its proprietary all-in-human CONVERGE platform integrates large-scale multi-omic patient datasets derived from human tissue with machine learning to identify novel therapeutic targets, and has been applied in pharmaceutical collaborations with Eli Lilly, AstraZeneca and Alexion. As of enrichment, the company exposes no public developer API, developer portal, SDK, or machine-readable API specification; CONVERGE is an internal research platform, not a consumer-facing API.

Verge Genomics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Genomics, and Artificial Intelligence.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyDrug DiscoveryGenomicsArtificial IntelligenceMachine LearningHealthcareNeuroscience

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/verge-genomics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Other 1

Properties that don't map to a standard resource type

Approach

Approach

Source (apis.yml)

aid: verge-genomics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/verge-genomics.png
name: Verge Genomics
description: Verge Genomics (now operating as Verge Labs) is an AI-driven drug discovery biotechnology company using human
  genomics data and machine learning to discover and develop treatments for neurodegenerative and neuromuscular diseases such
  as ALS and Parkinson's. Its proprietary all-in-human CONVERGE platform integrates large-scale multi-omic patient datasets
  derived from human tissue with machine learning to identify novel therapeutic targets, and has been applied in pharmaceutical
  collaborations with Eli Lilly, AstraZeneca and Alexion. As of enrichment, the company exposes no public developer API, developer
  portal, SDK, or machine-readable API specification; CONVERGE is an internal research platform, not a consumer-facing API.
url: https://raw.githubusercontent.com/api-evangelist/verge-genomics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://vergelabs.com/
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Drug Discovery
- Genomics
- Artificial Intelligence
- Machine Learning
- Healthcare
- Neuroscience
apis: []
common:
- type: Website
  url: https://vergelabs.com/
- type: Approach
  url: https://www.vergegenomics.com/approach
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1